Arrhythmias & electrophysiology

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

EuropacePublished Prognostic model validation study

Authors' conclusion

The PLN p.(Arg14del) risk model has sustained good model performance up to 3 years follow-up in PLN p.(Arg14del)-positive subjects with no history of major VA.

Study context

Population
PLN p.(Arg14del)-positive individuals with no prior major ventricular arrhythmia (VA) at the 3-year landmark
Participants
268 participants
Outcome
Diagnostic performance of the PLN p.(Arg14del) risk model for major VA (sustained VA, appropriate implantable cardioverter defibrillator (ICD) intervention or (aborted) SCD)
Follow-up
3-year follow-up
Methodological detailslandmark analysis
  • Landmark analysis

Performance

As reported in the abstract

Risk model performance in the 3-year landmark cohort

C-statistic

0.83

95% CI 0.79–0.87

Calibration slope

0.97

Further findings

Major VA after the 3-year landmark · mean follow-up 4.0 years (± 3.5 years)

Subjects with major VA
28 (10%)
Annual event rate
2.6% (95% CI 1.6-3.6)

Original publication

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study. Europace. Published 1 April 2024. doi:10.1093/europace/euae069

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.